- Home
- MMI vs SANA Comparison
MMI vs SANA Comparison
Compare MMI & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMI
- SANA
- Stock Information
- Founded
- MMI 1971
- SANA 2018
- Country
- MMI United States
- SANA United States
- Employees
- MMI N/A
- SANA N/A
- Industry
- MMI Real Estate
- SANA Medicinal Chemicals and Botanical Products
- Sector
- MMI Finance
- SANA Health Care
- Exchange
- MMI Nasdaq
- SANA Nasdaq
- Market Cap
- MMI 1.2B
- SANA 983.4M
- IPO Year
- MMI 2013
- SANA 2021
- Fundamental
- Price
- MMI $29.25
- SANA $5.02
- Analyst Decision
- MMI Hold
- SANA Strong Buy
- Analyst Count
- MMI 1
- SANA 6
- Target Price
- MMI N/A
- SANA $8.00
- AVG Volume (30 Days)
- MMI 134.5K
- SANA 5.7M
- Earning Date
- MMI 11-07-2025
- SANA 11-07-2025
- Dividend Yield
- MMI 1.71%
- SANA N/A
- EPS Growth
- MMI N/A
- SANA N/A
- EPS
- MMI N/A
- SANA N/A
- Revenue
- MMI $725,903,000.00
- SANA N/A
- Revenue This Year
- MMI $9.50
- SANA N/A
- Revenue Next Year
- MMI $17.73
- SANA N/A
- P/E Ratio
- MMI N/A
- SANA N/A
- Revenue Growth
- MMI 17.89
- SANA N/A
- 52 Week Low
- MMI $27.35
- SANA $1.26
- 52 Week High
- MMI $42.80
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- MMI 46.01
- SANA 62.92
- Support Level
- MMI $28.79
- SANA $4.10
- Resistance Level
- MMI $29.62
- SANA $6.55
- Average True Range (ATR)
- MMI 0.67
- SANA 0.50
- MACD
- MMI 0.14
- SANA 0.13
- Stochastic Oscillator
- MMI 80.67
- SANA 50.32
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.